V1RG9 Activators

Chemical activators of V1RG9 function by modulating various intracellular signaling pathways, leading to the phosphorylation and subsequent activation of the protein. Forskolin, by activating adenylate cyclase, increases the intracellular concentrations of cAMP. This surge in cAMP levels activates protein kinase A (PKA), which can directly phosphorylate V1RG9. Similarly, IBMX maintains elevated levels of cAMP and cGMP by inhibiting phosphodiesterases, indirectly facilitating the activation of PKA or protein kinase G (PKG), which then can also target V1RG9 for phosphorylation. Sildenafil, specifically targeting phosphodiesterase 5, increases cGMP levels, selectively activating PKG, which then phosphorylates V1RG9. PMA, on the other hand, directly activates protein kinase C (PKC) which has a range of protein targets, including V1RG9, leading to its activation through phosphorylation.

Calcium ionophores like Ionomycin and A-23187 increase intracellular calcium levels, which can activate a variety of calcium-dependent kinases capable of phosphorylating V1RG9. Histamine triggers the phospholipase C pathway, resulting in the generation of inositol triphosphate (IP3) and diacylglycerol (DAG). These secondary messengers lead to the release of Ca2+ from intracellular stores and activation of PKC, respectively, with PKC then able to phosphorylate V1RG9. Nicotine engages with nicotinic acetylcholine receptors, leading to an influx of Ca2+, which activates calcium-dependent kinases that target V1RG9. Glutamate, through its action on NMDA receptors, similarly causes a Ca2+ influx, thereby activating kinases such as CaMKII, which phosphorylates V1RG9. ATP, through its interaction with purinergic receptors, initiates signaling cascades that activate kinases which then phosphorylate V1RG9. Capsaicin activates TRPV1 channels causing calcium influx and activation of calcium-dependent kinases that phosphorylate V1RG9. Lastly, the binding of Epidermal Growth Factor (EGF) to its receptor initiates a cascade of kinase activations culminating in the phosphorylation of V1RG9.